Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA071468-05
Application #
6172982
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Lively, Tracy (LUGO)
Project Start
1996-08-23
Project End
2000-08-31
Budget Start
2000-06-01
Budget End
2000-08-31
Support Year
5
Fiscal Year
2000
Total Cost
$90,677
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28
Scott, Gary K; Chu, David; Kaur, Ravneet et al. (2017) ERpS294 is a biomarker of ligand or mutational ER? activation and a breast cancer target for CDK2 inhibition. Oncotarget 8:83432-83445
Troester, Melissa A; Hoadley, Katherine A; D'Arcy, Monica et al. (2016) DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas. NPJ Breast Cancer 2:16007
Laberge, Remi-Martin; Sun, Yu; Orjalo, Arturo V et al. (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 17:1049-61
Hoadley, Katherine A; Yau, Christina; Wolf, Denise M et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158:929-944
Goncalves, Renata L S; Rothschild, Daniel E; Quinlan, Casey L et al. (2014) Sources of superoxide/H2O2 during mitochondrial proline oxidation. Redox Biol 2:901-9
Zawadzka, Anna M; Schilling, Birgit; Cusack, Michael P et al. (2014) Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. Mol Cell Proteomics 13:1034-49
Wilson-Edell, Kathleen A; Kehasse, Amanuel; Scott, Gary K et al. (2014) RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. Oncotarget 5:5165-76
Wilson-Edell, Kathleen A; Yevtushenko, Mariya A; Rothschild, Daniel E et al. (2014) mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms. Breast Cancer Res Treat 144:287-298
Held, Jason M; Britton, David J; Scott, Gary K et al. (2012) Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305. Mol Cancer Res 10:1120-32

Showing the most recent 10 out of 38 publications